Form 4: Bio-Techne Corp Director Exercises Stock Options and Acquires Shares
SEC Form 4 Filing
Director John L. Higgins exercised stock options to acquire 12,000 shares of Bio-Techne Corp common stock at a price of $21.84 on May 1, 2025.
Summary
- On May 1, 2025, John L. Higgins, a director of Bio-Techne Corp, exercised stock options to acquire 12,000 shares of common stock at $21.84 per share.
- Following the transaction, Higgins directly owns 60,196 shares of Bio-Techne Corp common stock.
- Higgins also holds various stock options with exercise prices ranging from $25.3 to $128.81, expiring between 2026 and 2034.
- The exercised options had been granted on October 29, 2016, with an exercise price of $21.84.
- The options granted on October 24, 2024, vest on the earlier of the one-year anniversary of the grant date or the date of Bio-Techne's 2025 annual meeting of shareholders.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing detailing a stock option exercise. While insider buying can be seen as a positive signal, this is a routine transaction.
Positives
- The exercise of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
- Higgins' increased stake in the company aligns his interests with those of other shareholders.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Monitoring these filings can offer insights into management's sentiment and expectations for the company's future.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder sentiment due to the director's increased investment in the company.
Key Dates
| Date | Description |
|---|---|
| 10/29/2016 | Grant date of stock options exercised on 05/01/2025 |
| 10/26/2017 | Grant date of stock options expiring on 10/26/2026 |
| 10/25/2018 | Grant date of stock options expiring on 10/26/2027 |
| 10/24/2019 | Grant date of stock options expiring on 10/25/2028 |
| 10/24/2020 | Grant date of stock options expiring on 10/24/2029 |
| 10/28/2021 | Grant date of stock options expiring on 10/29/2030 |
| 10/27/2022 | Grant date of stock options expiring on 10/28/2031 |
| 10/26/2023 | Grant date of stock options expiring on 10/27/2032 |
| 10/24/2024 | Grant date of stock options expiring on 10/26/2033 and 10/24/2034 |
| 05/01/2025 | Date of transaction: Director John L. Higgins exercised stock options. |
| 10/24/2025 | Vesting date of options granted on 10/24/2024, if earlier than the 2025 annual meeting. |
Keywords
Bio-Techne, Director, Stock Options, Form 4, Insider Trading, TECH, Higgins, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.